<table class="infobox infobox-disease">
<tr>
<th class="infobox-header" colspan="2">Guam ALS-PDC</th>
</tr>
<tr> [@garruto1986]
<td class="label">Also Known As</td> [@kimura1979]
<td>ALS-PDC, Lytico-Bodig Disease, Chamorro Disease</td> [@plato2002]
</tr> [@banack2003]
<tr> [@boursi2017]
<td class="label">Classification</td> [@mastroeni2017]
<td>Motor Neuron Disease + Parkinsonian Dementia</td> [@last2026]
</tr>
<tr>
<td class="label">Region</td>
<td>Guam (Chamorro population)</td>
</tr>
<tr>
<td class="label">First Described</td>
<td>1940s-1950s</td>
</tr>
<tr>
<td class="label">Prevalence</td>
<td>Previously 10% of adult deaths; now rare</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>105400</td>
</tr>
</table>
Guam Als Parkinsonism Dementia Complex (Als Pdc) is a progressive neurodegenerative disorder characterized by the gradual loss of neuronal function. This page provides comprehensive information about the disease, including its pathophysiology, clinical presentation, diagnosis, and current therapeutic approaches.
<table class="infobox infobox-disease">
<tr>
<th class="infobox-header" colspan="2">Guam ALS-PDC</th>
</tr>
<tr> [@garruto1986]
<td class="label">Also Known As</td> [@kimura1979]
<td>ALS-PDC, Lytico-Bodig Disease, Chamorro Disease</td> [@plato2002]
</tr> [@banack2003]
<tr> [@boursi2017]
<td class="label">Classification</td> [@mastroeni2017]
<td>Motor Neuron Disease + Parkinsonian Dementia</td> [@last2026]
</tr>
<tr>
<td class="label">Region</td>
<td>Guam (Chamorro population)</td>
</tr>
<tr>
<td class="label">First Described</td>
<td>1940s-1950s</td>
</tr>
<tr>
<td class="label">Prevalence</td>
<td>Previously 10% of adult deaths; now rare</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>105400</td>
</tr>
</table>
Guam Als Parkinsonism Dementia Complex (Als Pdc) is a progressive neurodegenerative disorder characterized by the gradual loss of neuronal function. This page provides comprehensive information about the disease, including its pathophysiology, clinical presentation, diagnosis, and current therapeutic approaches.
Guam ALS-Parkinsonism-Dementia Complex (ALS-PDC), also known locally as Lytico-Bodig disease, is a unique neurodegenerative disorder that was historically prevalent among
the Chamorro people of Guam[@kurland1965]. This condition is remarkable because it combines features of amyotrophic lateral sclerosis (ALS), Parkinson's Disease, and dementia within a single
individual, representing one of the most complex neurodegenerative syndromes ever described[@steele2001].
First documented by Japanese and American physicians in the 1940s and 1950s, Guam ALS-PDC reached epidemic proportions in the mid-20th century, accounting for up to 10% of adult
deaths on Guam[@plato2000]. The dramatic decline in incidence over subsequent decades has made it a focal point for understanding potential environmental and
genetic factors in neurodegeneration[@cox2002].
The ALS-like presentation in Guam ALS-PDC includes:
The parkinsonian features include:
Cognitive and behavioral changes include:
Guam ALS-PDC was almost exclusively found in the Chamorro population of Guam, with particularly high rates in the villages of Umatac, Merizo, and Inarajan[@garruto1986].
The disease reached peak prevalence in the 1950s-1960s, with some villages reporting that ALS-PDC caused up to 50% of all adult deaths[@kimura1979]. By the 1980s, the incidence had declined dramatically, suggesting either environmental factor removal or genetic adaptation<a
href="#references" class="ref-link" data-ref-number="7" data-ref-text="Plato CC, Galasko D, et al. "Lytico-Bodig disease: chronic ALS and Parkinsonism in Guam." *Adv
Neurol. 2002;91:229-244." title="Plato CC, Galasko D, et al. "Lytico-Bodig disease: chronic ALS and Parkinsonism in Guam." Adv Neurol. 2002;91:229-244."> class="ref-link" data-ref-number="7" data-ref-text="Plato CC, Galasko D, et al. "Lytico-Bodig disease: chronic ALS and Parkinsonism in Guam." Adv Neurol. 2002;91:229-244." title="Plato CC, Galasko D, et al. "Lytico-Bodig disease: chronic ALS and Parkinsonism in Guam." Adv Neurol*. 2002;91:229-244.">7</a></a>.
Typically presents in the 5th-6th decade of life, with slight earlier onset in males.
The leading environmental hypothesis implicates consumption of cycad seeds (Cycas circinalis), which were traditionally used as a source of food during famine periods[@banack2003]. Cycad seeds contain:
Alternative theories suggest possible roles for:
While the disease shows apparent clustering in families, no clear Mendelian inheritance pattern has been established[@boursi2017]. Studies have identified possible susceptibility loci, but definitive genetic causes remain elusive.
Key pathological features include:
The decline of Guam ALS-PDC has been attributed to:
No disease-modifying treatments exist specifically for Guam ALS-PDC. Management is symptomatic and includes:
Current research focuses on:
Guam ALS-PDC represents a unique overlap between several neurodegenerative conditions:
| Feature | Guam ALS-PDC | ALS | Parkinson's | Alzheimer's |
|---------|--------------|-----|-------------|-------------|
| Motor neuron degeneration | + | +++ | - | - |
| Substantia nigra loss | ++ | - | +++ | - |
| [Tau](/proteins/tau) pathology | ++ | - | + | +++ |
| [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology | ++ | +++ | - | - |
| Cognitive decline | +++ | + | + | +++ |
The study of Guam Als Parkinsonism Dementia Complex (Als Pdc) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Recent publications on Guam ALS-Parkinsonism-Dementia Complex.